James Ohara
Internal Medicine · New Britain, CTNPI 1770584724
Payments from drug & device makers
Across 187 payments — averaging $18.48 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boehringer Ingelheim$444
- Pfizer$340
- E.r. Squibb & Sons, L.L.C.$268
- AbbVie$229
- Novo Nordisk$217
- GSK$188
- plus $2K from 25 others
What the payments were for
- Food & beverage$3,456100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boehringer Ingelheim | 21 | $444 |
| Pfizer | 22 | $340 |
| E.r. Squibb & Sons, L.L.C. | 14 | $268 |
| AbbVie(2 entities) | 10 | $229 |
| Novo Nordisk | 10 | $217 |
| GSK | 10 | $188 |
| Amarin Pharma, Inc. | 10 | $172 |
| Abbott | 8 | $158 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 8 | $157 |
| Merck | 10 | $155 |
| Lilly USA, LLC | 8 | $139 |
| AstraZeneca(2 entities) | 9 | $135 |
| Bayer | 5 | $129 |
| Novartis | 6 | $112 |
| Astellas Pharma US Inc | 6 | $82 |
| Amgen | 4 | $79 |
| Johnson & Johnson | 4 | $53 |
| Hikma Pharmaceuticals USA | 3 | $49 |
| Exact Sciences | 2 | $44 |
| Kowa Pharmaceuticals America, Inc. | 3 | $42 |
| Idorsia Pharmaceuticals US Inc | 2 | $41 |
| Shire North American Group Inc | 2 | $30 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $30 |
| Genentech USA, Inc. | 2 | $26 |
| Dexcom, Inc. | 1 | $25 |
| Daiichi Sankyo Inc. | 1 | $22 |
| VBI Vaccine (delaware) Inc. | 1 | $21 |
| Scilex Pharmaceuticals Inc. | 1 | $19 |
| Eisai Inc. | 1 | $17 |
| Mylan Specialty L.p. | 1 | $17 |
| Sanofi Pasteur Inc. | 1 | $16 |
How this compares
$3,456 in reported general payments places this provider in the 85th percentile of 2,067 internal medicine providers in Connecticut.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Phenytoin Sodium Extended | 14 | $242 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in New Britain
- Joseph SouferWaterbury$21.5M
- David RadinStamford$7M
- Steven RyderWestport$3.9M
- Nancy BrownNew Haven$2.8M
- Charles MontanoCromwell$2.8M
- Arthur DecillisMadison$1M
- Michelle MallitzTrumbull$971K
- Allen HellerWoodbridge$758K
- Gary BlickNorwalk$717K
- Margaret ChusteckaHamden$652K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.